Report Detail

Pharma & Healthcare Global mRNA Vaccine Market Insights, Forecast to 2025

  • RnM2753637
  • |
  • 06 June, 2019
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 mRNA Vaccine Market Overview

    • 1.1 Product Overview and Scope of mRNA Vaccine
    • 1.2 mRNA Vaccine Segment by Type
      • 1.2.1 Global mRNA Vaccine Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
      • 1.2.3 Individualized Cancer Treatment MRNA Vaccine
      • 1.2.4 Infectious Disease Treatment MRNA Vaccine
      • 1.2.5 Infection Prevention MRNA Vaccine
    • 1.3 mRNA Vaccine Segment by Application
      • 1.3.1 mRNA Vaccine Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Infectious Disease
      • 1.3.3 Cancer
      • 1.3.4 Other
    • 1.4 Global mRNA Vaccine Market Size Estimates and Forecasts
      • 1.4.1 Global mRNA Vaccine Revenue 2015-2026
      • 1.4.2 Global mRNA Vaccine Sales 2015-2026
      • 1.4.3 mRNA Vaccine Market Size by Region: 2020 Versus 2026

    2 Global mRNA Vaccine Market Competition by Manufacturers

    • 2.1 Global mRNA Vaccine Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global mRNA Vaccine Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers mRNA Vaccine Manufacturing Sites, Area Served, Product Type
    • 2.5 mRNA Vaccine Market Competitive Situation and Trends
      • 2.5.1 mRNA Vaccine Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders)

    3 mRNA Vaccine Retrospective Market Scenario by Region

    • 3.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America mRNA Vaccine Market Facts & Figures by Country
      • 3.3.1 North America mRNA Vaccine Sales by Country
      • 3.3.2 North America mRNA Vaccine Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe mRNA Vaccine Market Facts & Figures by Country
      • 3.4.1 Europe mRNA Vaccine Sales by Country
      • 3.4.2 Europe mRNA Vaccine Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific mRNA Vaccine Market Facts & Figures by Region
      • 3.5.1 Asia Pacific mRNA Vaccine Sales by Region
      • 3.5.2 Asia Pacific mRNA Vaccine Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America mRNA Vaccine Market Facts & Figures by Country
      • 3.6.1 Latin America mRNA Vaccine Sales by Country
      • 3.6.2 Latin America mRNA Vaccine Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa mRNA Vaccine Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa mRNA Vaccine Sales by Country
      • 3.7.2 Middle East and Africa mRNA Vaccine Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global mRNA Vaccine Historic Market Analysis by Type

    • 4.1 Global mRNA Vaccine Sales Market Share by Type (2015-2020)
    • 4.2 Global mRNA Vaccine Revenue Market Share by Type (2015-2020)
    • 4.3 Global mRNA Vaccine Price Market Share by Type (2015-2020)
    • 4.4 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global mRNA Vaccine Historic Market Analysis by Application

    • 5.1 Global mRNA Vaccine Sales Market Share by Application (2015-2020)
    • 5.2 Global mRNA Vaccine Revenue Market Share by Application (2015-2020)
    • 5.3 Global mRNA Vaccine Price by Application (2015-2020)

    6 Company Profiles and Key Figures in mRNA Vaccine Business

    • 6.1 Moderna Therapeutics
      • 6.1.1 Corporation Information
      • 6.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue
      • 6.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Moderna Therapeutics Products Offered
      • 6.1.5 Moderna Therapeutics Recent Development
    • 6.2 CureVac
      • 6.2.1 CureVac mRNA Vaccine Production Sites and Area Served
      • 6.2.2 CureVac Description, Business Overview and Total Revenue
      • 6.2.3 CureVac mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 CureVac Products Offered
      • 6.2.5 CureVac Recent Development
    • 6.3 Translate Bio
      • 6.3.1 Translate Bio mRNA Vaccine Production Sites and Area Served
      • 6.3.2 Translate Bio Description, Business Overview and Total Revenue
      • 6.3.3 Translate Bio mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Translate Bio Products Offered
      • 6.3.5 Translate Bio Recent Development
    • 6.4 BioNTech
      • 6.4.1 BioNTech mRNA Vaccine Production Sites and Area Served
      • 6.4.2 BioNTech Description, Business Overview and Total Revenue
      • 6.4.3 BioNTech mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 BioNTech Products Offered
      • 6.4.5 BioNTech Recent Development
    • 6.5 Sangamo Therapeutics
      • 6.5.1 Sangamo Therapeutics mRNA Vaccine Production Sites and Area Served
      • 6.5.2 Sangamo Therapeutics Description, Business Overview and Total Revenue
      • 6.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Sangamo Therapeutics Products Offered
      • 6.5.5 Sangamo Therapeutics Recent Development
    • 6.6 Argos Therapeutics
      • 6.6.1 Argos Therapeutics mRNA Vaccine Production Sites and Area Served
      • 6.6.2 Argos Therapeutics Description, Business Overview and Total Revenue
      • 6.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Argos Therapeutics Products Offered
      • 6.6.5 Argos Therapeutics Recent Development
    • 6.7 In-Cell-Art
      • 6.6.1 In-Cell-Art mRNA Vaccine Production Sites and Area Served
      • 6.6.2 In-Cell-Art Description, Business Overview and Total Revenue
      • 6.6.3 In-Cell-Art mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 In-Cell-Art Products Offered
      • 6.7.5 In-Cell-Art Recent Development
    • 6.8 eTheRNA
      • 6.8.1 eTheRNA mRNA Vaccine Production Sites and Area Served
      • 6.8.2 eTheRNA Description, Business Overview and Total Revenue
      • 6.8.3 eTheRNA mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 eTheRNA Products Offered
      • 6.8.5 eTheRNA Recent Development
    • 6.9 Ethris
      • 6.9.1 Ethris mRNA Vaccine Production Sites and Area Served
      • 6.9.2 Ethris Description, Business Overview and Total Revenue
      • 6.9.3 Ethris mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Ethris Products Offered
      • 6.9.5 Ethris Recent Development
    • 6.10 Tiba Biotechnology
      • 6.10.1 Tiba Biotechnology mRNA Vaccine Production Sites and Area Served
      • 6.10.2 Tiba Biotechnology Description, Business Overview and Total Revenue
      • 6.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Tiba Biotechnology Products Offered
      • 6.10.5 Tiba Biotechnology Recent Development

    7 mRNA Vaccine Manufacturing Cost Analysis

    • 7.1 mRNA Vaccine Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of mRNA Vaccine
    • 7.4 mRNA Vaccine Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 mRNA Vaccine Distributors List
    • 8.3 mRNA Vaccine Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global mRNA Vaccine Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of mRNA Vaccine by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of mRNA Vaccine by Type (2021-2026)
    • 10.2 mRNA Vaccine Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of mRNA Vaccine by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of mRNA Vaccine by Application (2021-2026)
    • 10.3 mRNA Vaccine Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of mRNA Vaccine by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of mRNA Vaccine by Region (2021-2026)
    • 10.4 North America mRNA Vaccine Estimates and Projections (2021-2026)
    • 10.5 Europe mRNA Vaccine Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific mRNA Vaccine Estimates and Projections (2021-2026)
    • 10.7 Latin America mRNA Vaccine Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa mRNA Vaccine Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global mRNA Vaccine market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on mRNA Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mRNA Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the mRNA Vaccine market is segmented into
      Standardization Of Cancer Treatment MRNA Vaccine
      Individualized Cancer Treatment MRNA Vaccine
      Infectious Disease Treatment MRNA Vaccine
      Infection Prevention MRNA Vaccine

      Segment by Application
      Infectious Disease
      Cancer
      Other

      Global mRNA Vaccine Market: Regional Analysis
      The mRNA Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the mRNA Vaccine market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global mRNA Vaccine Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global mRNA Vaccine market include:
      Moderna Therapeutics
      CureVac
      Translate Bio
      BioNTech
      Sangamo Therapeutics
      Argos Therapeutics
      In-Cell-Art
      eTheRNA
      Ethris
      Tiba Biotechnology


      Summary:
      Get latest Market Research Reports on mRNA Vaccine . Industry analysis & Market Report on mRNA Vaccine is a syndicated market report, published as Global mRNA Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of mRNA Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $4,350.00
      $5,800.00
      2,361.74
      3,542.61
      4,723.49
      2,638.90
      3,958.36
      5,277.81
      312,443.10
      468,664.65
      624,886.20
      219,619.03
      329,428.55
      439,238.06
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report